⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8297918 | 0.85 | — | — | |
| SCHEMBL868397 | 0.74 | MAPT (0.35) | — | |
| SCHEMBL28342953 | 0.72 | — | — | |
| SCHEMBL5264131 | 0.72 | — | — | |
| SCHEMBL17501314 | 0.71 | — | — | |
| Boric Acid SCHEMBL6813589 | 0.70 | POLB (0.35) | — | |
| SCHEMBL18878410 | 0.69 | ALOX5 (0.33) | — | |
| SCHEMBL18562866 | 0.69 | ENPP2 (0.40) | — | |
| SCHEMBL3786383 | 0.69 | LIPG (0.37) | — | |
| SCHEMBL20561503 | 0.67 | MGLL (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119235877-A | Composition of ruthenium (III) acid salt and application thereof | 中山大学 | 2025-01-03 | — | — | CN | claimed |
| CN-113956268-B | 6-bromo-1-chlorobenzothiophene [2,3-c ] pyridine and synthetic method | 西安欧得光电材料有限公司 | 2022-07-15 | — | — | CN | claimed |
| CN-109705055-B | Benzothiazole compound, preparation method thereof and application of benzothiazole compound as hypobromous acid probe | 湖南城市学院 | 2022-05-13 | — | — | CN | claimed |
| CN-113956268-A | 6-bromo-1-chlorobenzothiophene [2,3-c ] pyridine and synthetic method | 西安欧得光电材料有限公司 | 2022-01-21 | — | — | CN | claimed |
| CN-121494773-B | Synthesis method of thioether ligand and palladium-catalyzed 2-aryl indole compound | 九洲药业(杭州)有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-121627741-A | Method and system for continuously preparing 2-methylthiophenylboronic acid by micro-channel reactor | 山东弗鲁微科技有限公司 | 2026-03-10 | — | — | CN | disclosed |
| CN-121627741-A | Method and system for continuously preparing 2-methylthiophenylboronic acid by micro-channel reactor | 山东弗鲁微科技有限公司 | 2026-03-10 | — | — | CN | disclosed |
| CN-119235877-B | Composition of ruthenium (III) acid salt and application thereof | 中山大学 | 2025-11-11 | — | — | CN | disclosed |
| EP-4638446-A1 | THIADIAZOLE DERIVATIVES AS INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF | Ventus Therapeutics U.S., Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| US-12398097-B2 | WDR5-MYC inhibitors | VANDERBILT UNIVERSITY (US) | 2025-08-26 | — | — | US | disclosed |
| EP-3351533-B1 | BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME | KAKEN PHARMA CO LTD (JP) | 2025-07-23 | — | — | EP | disclosed |
| CN-120118064-A | Anthracene compound containing dibenzoheterocycle and application thereof | 阜阳欣奕华新材料科技股份有限公司 | 2025-06-10 | — | — | CN | disclosed |
| WO-1998057937-A2 | INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-12-23 | — | — | WO | disclosed |
| US-5824691-A | CARDIOVASCULAR, CEREBROVASCULAR, RENAL DISEASES; SHOCK, ARTERIOSCLEROSIS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-20 | — | — | US | disclosed |
| WO-1998028269-A1 | NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS | DU PONT PHARMACEUTICALS COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998028282-A2 | OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS | DU PONT PHARMACEUTICALS COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| EP-0773927-A2 | BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-05-21 | — | — | EP | disclosed |
| EP-0699185-A1 | GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-03-06 | — | — | EP | disclosed |
| WO-1996004241-A2 | BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-02-15 | — | — | WO | disclosed |
| WO-1994026709-A1 | GUANIDINE DERIVATIVES AS INHIBITORS OF Na+/H+ EXCHANGE IN CELLS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-11-24 | — | — | WO | disclosed |